期刊文献+

红细胞分布宽度与特发性肺动脉高压病情和预后的相关性分析 被引量:23

Correlation Study Between Red Cell Distribution Width With the Condition and Prognosis in Patients of Idiopathic Pulmonary Arterial Hypertension
下载PDF
导出
摘要 目的:探讨红细胞分布宽度(RDW)与特发性肺动脉高压病情和预后的相关性。方法:连续入选经右心导管确诊为特发性肺动脉高压的患者76例。以RDW 13.5%作为界值将患者分为RDW≥13.5%组(n=43)与RDW<13.5%组(n=33)。对基线资料进行相关性分析及分组探讨,对随访结果绘制ROC曲线并作生存分析及COX回归。结果:相关分析结果显示,RDW与WHO肺动脉高压功能分级、右心室舒张末期前后径、N末端B型利钠肽原(NT-ProBNP)、大内皮素1呈正相关(r=0.40,P<0.001;r=0.29,P=0.013;r=0.36,P=0.002;r=0.31,P=0.012),与六分钟步行距离、左心室舒张末期前后径、心指数呈负相关(r=-0.3,P=0.029;r=-0.3,P=0.01;r=-0.27,P=0.019)。与NT-ProBNP、大内皮素-1相比,只有RDW预测患者两年内不良事件(死亡)发生的ROC曲线有统计学意义(P=0.003),曲线下面积0.766,以RDW 13.5%作为界值预测患者死亡的敏感度为0.9,特异度为0.7。Kaplan-Meier生存曲线:RDW<13.5%组预后明显好于RDW≥13.5%组,log-rank检验P<0.001,差异有统计学意义。RDW≥13.5%组患者的肺动脉高压功能分级、NT-ProBNP和大内皮素-1水平较RDW<13.5%组偏高,差异有统计学意义(P<0.05)。多因素COX回归显示,排除其他因素影响后,RDW≥13.5%仍是患者死亡的独立危险因素。结论:RDW与特发性肺动脉高压的病情和预后相关。高水平的RDW提示病情较重,预后较差,也是发生不良事件的独立危险因素。 Objective: To explore the relationship between circulating red cell distribution width (RDW) with the condition and prognosis in patients of idiopathic pulmonary arterial hypertension (IPAH). Methods: A total of 76 consecutive IPAH patients with confirmed diagnosis of right heart catheterization were enrolled in our work. Taking the cut-offvalue of RDW=13.5%, the patients were divided into 2 groups as RDW≥ 13.5% group, n=43 and RDW〈13.5% group, n=33. The baseline condition was recorded and compared between 2 groups and the follow-up outcome was studied with ROC curves and Cox regression survival analysis. Results: The correlation analysis indicated that RDW level positively related to WHO functional class (WHO-FC), (r = 0.40, P〈0.001), right ventricular end diastolic diameter (r=0.29, P=0.013), NT-ProBNP (r=-0.36, P=0.002), endothelin-1 (r=0.3 1, P= 0.012); and negatively related to 6 minutes walking distance (r=-0.3, P=0.029), left ventricular end diastolic diameter (r=-0.3, P=0.01), and cardiac index (r =-0.27, P=0.019). ROC curve presented that compared with NT-ProBNP and endothelin-1, RDW was the effective predictor for 2 year all-cause mortality in IPAH patients, P=0.003, the area under the curve was 0.766. Based on cut-off value of 13.5%, the sensitivity for RDW prediction in IPAH mortality was 88.9%, in specificity was 66.7%. Survival analysis showed that RDW〈13.5% group had better prognosis than RDW ≥ 13.5% group, P〈0.001. RDW ≥13.5% group had higfier levels of WHO-FC, NT-ProBNP and endothelin-1 than that in RDW〈13.5% group, P〈0.05.Multi-Cox regression analysis suggested that RDW ≥ 13.5% is an independent risk factor for death in IPAH patients. Conclusion: RDW level related to clinical condition and prognosis in IPAH patients. Higher level of RDW indicated worse condition with poor prognosis, it was an independent risk factor for adverse events.
出处 《中国循环杂志》 CSCD 北大核心 2013年第2期111-114,共4页 Chinese Circulation Journal
基金 国家“十一五”科技支撑计划资助项目(2006BA101A07) 首都医学发展科研基金项目(2009-1003)
关键词 红细胞分布宽度 特发性肺动脉高压 预后 Red cell distribution width Idiopathic pulmonary arterial hypertension Prognosis
  • 相关文献

参考文献9

  • 1程显声.特发性肺动脉高压的诊断[J].中国循环杂志,2006,21(6):478-480. 被引量:8
  • 2曾伟杰,孙云娟,卢献灵,熊长明,顾晴,倪新海,柳志红,程显声,何建国.5型磷酸二酯酶抑制剂改善特发性肺动脉高压患者预后[J].中国循环杂志,2011,26(2):117-120. 被引量:5
  • 3Vaya A, Hern6ndez JL, Zorio E, et al. Association between red blood cell distribution width and the risk of future cardiovascular events. Clin Hemorheol Microcirc, 2012, 50: 221-225. 被引量:1
  • 4Bonaque JC, Pascual-Figal DA, Manzano-Fernandez S, et al. Red blood cell distribution width adds prognostic value for outpatients with chronic heart failure. Rev Esp Cardiol, 2012, 65:606-612. 被引量:1
  • 5Rhodes C J, Wharton J, Howard LS, et al. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart, 2011, 97:1054- 1060. 被引量:1
  • 6Hampole CV, Mehrotra AK, Thenappan T, et al. Usefulness of red cell distribution width as a prognostic marker in pulmunary hypertension. Am J Cardiol, 2009, 104: 868-872. 被引量:1
  • 7Rhodes C J, Wharton J, Howard L, et al. Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target. Eur Respir J, 2011, 38:1453-1460. 被引量:1
  • 8Ruiter G, Lankhorst S, Boonstra A, et al. Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur Respir J, 2011, 37:1386-1391. 被引量:1
  • 9Frhcz Z, Gomhos T, Borgulya G, et al. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart I, 2009, 158: 659-666. 被引量:1

二级参考文献19

  • 1程显声.特发性肺动脉高压的诊断[J].中国循环杂志,2006,21(6):478-480. 被引量:8
  • 2D' Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Meal,1991,115(5) :343-349. 被引量:1
  • 3Jing ZC, Xu XQ, Han ZY, et al. Registry and survival study in chinese patients with idiopathic and familial puhnonary arterial hypertension. Chest, 2007,132 ( 2 ) : 373-379. 被引量:1
  • 4Galie N, Manes A, Negro L,et al. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J ,2009,30 (4) :394-403. 被引量:1
  • 5Galie N, Manes A, Negro L,et al. A meta-analysis of randomized con- trolled trials in pulmonary arterial hypertension. Eur Heart J ,2009,30 (4) :394-403. 被引量:1
  • 6McLaughlin V V, Archer SI., Badesch DB,et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians. American Thoracic Society, Inc. ; and the Pulmonary Hypertension Association. J Am Coil Cardiol,2009,53( 17 ) :1573-1619. 被引量:1
  • 7Takeda Y,Tomimoto S,Tani T,et al. Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension. BMC Pulm Med, 2010,10:22. 被引量:1
  • 8McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation, 2002, 106(12) :1477-1482. 被引量:1
  • 9Mehta S, Shoemaker GJ. hnproving survival in idiopathic pulmonary arterial hypertension : revisiting the '" kingdom of the near-dead". Thorax ,2005,60( 12 ) :981-983. 被引量:1
  • 10Shapiro SM, Oudiz RJ, Cao T, et al. Primary pulmonary hypertension : improved long-term effects and survival with continuous intravenous epoprostenol infusion. J Am Coil Cardiol, 1997,30 (2) :343-349. 被引量:1

共引文献11

同被引文献222

  • 1慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志(电子版),2014,6(2):67-80. 被引量:2032
  • 2荆志成.2010年中国肺高血压诊治指南[J].中国医学前沿杂志(电子版),2011,3(2):62-81. 被引量:117
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 4张启友.红细胞MCV和RDW参数对贫血的鉴别诊断[J].现代检验医学杂志,2007,22(6):125-125. 被引量:12
  • 5Tuder RM,Petrache I.Pathogenesis of chronic obstructive pulmonary disease[J].J Clin Invest,2012,122(8):2749-2755. 被引量:1
  • 6Perlstein MD,Jennifer W,Pfeffer MA,et al.Red blood cell distribution width and mortality risk in a community-based prospective cohert[J].Arch Intern Med,2009,169(6):588-594. 被引量:1
  • 7Van Kimmenade RR,Mohammed AA,Uthamalingam S,et al.Red blood cell distribution width and 1-year mortality in acute heart failure[J].Eur J Heart Fail,2010,12:129-136. 被引量:1
  • 8中华医学会心血管病分会,中华心血管病杂志编辑委员会,中国心肌病诊断与治疗建议工作组.心肌病诊断与治疗建议.中华心血管病杂志.2007,35:5-16. 被引量:3
  • 9Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension:The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). European Heart Journal, 2009,30:2493-2537. 被引量:1
  • 10Hirashiki A, Kondo T, Adaehi S, et al. Prognostic value of pulmonary hypertension in ambulatory patients with non-ischemic dilated cardiomyopathy. Circ J, 2014,78:1245-1253. 被引量:1

引证文献23

二级引证文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部